ArticleTrials2022

A novel trial methodology to test interventions with very large effect sizes: the case of dostarlimab in mismatch repair-deficient, locally advanced rectal cancer.

Kerrington Powell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.